reallyyy personal page - To The Moon

reallyyy

reallyyy

No personal profile

7Follow

0Followers

0Topic

0Badge

2022-05-25

Ok

Sorry, the original content has been removed

2022-05-12

Ok

Sorry, the original content has been removed

2022-05-12

Cool

Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming

2022-05-25

Hmm

Sorry, the original content has been removed

2022-05-23

$Apple(AAPL)$:(

2022-05-12

Ok

Sorry, the original content has been removed

2022-05-12

Ok

3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street

2022-05-25

Oh no

Sorry, the original content has been removed

2022-05-25

$ConocoPhillips(COP)$goo

2022-05-24

$Apple(AAPL)$hmm

2022-05-24

$ConocoPhillips(COP)$go

2022-05-23

$ConocoPhillips(COP)$up

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3584622221107394","uuid":"3584622221107394","gmtCreate":1625029068859,"gmtModify":1648087341694,"name":"reallyyy","pinyin":"reallyyy","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.11","exceedPercentage":"80.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9022985320,"gmtCreate":1653456036560,"gmtModify":1676535286094,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022985320","repostId":"1135977592","repostType":4,"repost":{"id":"1135977592","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1653449429,"share":"https://ttm.financial/m/news/1135977592?lang=&edition=fundamental","pubTime":"2022-05-25 11:30","market":"us","language":"en","title":"U.S. FDA Declines to Authorize Verrica's Viral Skin Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1135977592","media":"Reuters","summary":"(Reuters) - The U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals ","content":"<html><head></head><body><p>(Reuters) - The U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals Inc&#39;s drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.</p><p>The disease is caused by a pox virus and leads to skin-toned to pink-colored lesions that can cause pain, inflammation, itching and bacterial infection. While the lesions usually go away within a year without scarring, some cases could take a lot more time.</p><p>There are currently no approved treatments in the United States for the condition.</p><p>The FDA denied approval for Verrica&#39;s drug VP-102 due to deficiencies identified at Sterling Pharmaceuticals Services, a contract manufacturer that produces Verrica&#39;s bulk solution drug product, during a general re-inspection, which resulted in an Official Action Indicated (OAI) status.</p><p>An OAI is the FDA&#39;s most serious category of violation, and regulatory experts say it could lead to a prohibition on the sale of drugs from a facility if not addressed.</p><p>Verrica said it had been told that internal policy is preventing the health regulator from &#34;communicating the label and approving the NDA (New Drug Application)&#34; when a contract manufacturer is placed on OAI status.</p><p>None of the issues identified by the FDA during its re-inspection were specific to the manufacturing of VP-102, Verrica said in its statement.</p><p>The health regulator had declined Verrica&#39;s marketing application for the drug last year, citing general quality issues at one of the company&#39;s third-party manufacturing facilities. </p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. FDA Declines to Authorize Verrica's Viral Skin Disease Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. FDA Declines to Authorize Verrica's Viral Skin Disease Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-05-25 11:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>(Reuters) - The U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals Inc&#39;s drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.</p><p>The disease is caused by a pox virus and leads to skin-toned to pink-colored lesions that can cause pain, inflammation, itching and bacterial infection. While the lesions usually go away within a year without scarring, some cases could take a lot more time.</p><p>There are currently no approved treatments in the United States for the condition.</p><p>The FDA denied approval for Verrica&#39;s drug VP-102 due to deficiencies identified at Sterling Pharmaceuticals Services, a contract manufacturer that produces Verrica&#39;s bulk solution drug product, during a general re-inspection, which resulted in an Official Action Indicated (OAI) status.</p><p>An OAI is the FDA&#39;s most serious category of violation, and regulatory experts say it could lead to a prohibition on the sale of drugs from a facility if not addressed.</p><p>Verrica said it had been told that internal policy is preventing the health regulator from &#34;communicating the label and approving the NDA (New Drug Application)&#34; when a contract manufacturer is placed on OAI status.</p><p>None of the issues identified by the FDA during its re-inspection were specific to the manufacturing of VP-102, Verrica said in its statement.</p><p>The health regulator had declined Verrica&#39;s marketing application for the drug last year, citing general quality issues at one of the company&#39;s third-party manufacturing facilities. </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135977592","content_text":"(Reuters) - The U.S. Food and Drug Administration (FDA) declined to approve Verrica Pharmaceuticals Inc's drug for the treatment of a viral skin disease known as molluscum contagiosum, the company said on Tuesday.The disease is caused by a pox virus and leads to skin-toned to pink-colored lesions that can cause pain, inflammation, itching and bacterial infection. While the lesions usually go away within a year without scarring, some cases could take a lot more time.There are currently no approved treatments in the United States for the condition.The FDA denied approval for Verrica's drug VP-102 due to deficiencies identified at Sterling Pharmaceuticals Services, a contract manufacturer that produces Verrica's bulk solution drug product, during a general re-inspection, which resulted in an Official Action Indicated (OAI) status.An OAI is the FDA's most serious category of violation, and regulatory experts say it could lead to a prohibition on the sale of drugs from a facility if not addressed.Verrica said it had been told that internal policy is preventing the health regulator from \"communicating the label and approving the NDA (New Drug Application)\" when a contract manufacturer is placed on OAI status.None of the issues identified by the FDA during its re-inspection were specific to the manufacturing of VP-102, Verrica said in its statement.The health regulator had declined Verrica's marketing application for the drug last year, citing general quality issues at one of the company's third-party manufacturing facilities.","news_type":1},"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022982481,"gmtCreate":1653455992143,"gmtModify":1676535286078,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982481","repostId":"1129162543","repostType":4,"repost":{"id":"1129162543","pubTimestamp":1653445368,"share":"https://ttm.financial/m/news/1129162543?lang=&edition=fundamental","pubTime":"2022-05-25 10:22","market":"us","language":"en","title":"Tesla Stock Falls to an 11-Month Low, Why a Second-Tier Social Media Company Is to Blame","url":"https://stock-news.laohu8.com/highlight/detail?id=1129162543","media":"Barron's","summary":"Tesla stock tumbles 6.93% on Tuesday. The likeliest reason isn’t related to price-target actions at ","content":"<html><head></head><body><p>Tesla stock tumbles 6.93% on Tuesday. The likeliest reason isn’t related to price-target actions at a broker. However, the drop is probably because of the social-media platform Snap.</p><p><a href=\"https://laohu8.com/S/SNAP\">Snap</a> warned investors revenue would be weaker than expected Monday evening at the J.P. Morgan Technology, Media and Telecom conference.</p><p>“Well, the macroeconomic environment has definitely deteriorated further and faster than we expected when we issued our guidance for the second quarter,” said Snap CEO Evan Spiegel. “So even though our revenue continues to grow year-over-year in the second quarter, it’s likely that revenue and Ebitda will come in below the low end of our guidance range.” (Ebitda is short for earnings before interest, taxes, depreciation, and amortization.)</p><p>Snap expects second-quarter sales to come in between $1.179 billion and $1.228 billion. Wall Street was modeling $1.184 billion.</p><p>Snap stock is down 43%, at $12.79 on Tuesday, helping to drive the Nasdaq Composite down 2.35%. Tesla stock (TSLA) is off 6.94%, at $628.16. It would the lowest level since June 2021 if it were to close there.</p><p>Tesla is falling despite having made some progress on restoring its Shanghai plant to full production. Tesla is quarantining workers in preparation for a second shift at the Shanghai plant, Bloomberg reported Tuesday. Workers have to be Covid-19-free and isolated for the plant to operate in a “closed loop” setting—essentially having virus-free workers who have no contact with the outside world.</p><p>Tesla’s Shanghai plant was shut completely for weeks in early April. The plant has been operating at reduced capacity since late that month. Many workers are living at the plant, largely because it’s an opportunity to get paid after weeks of isolating at home. Tesla didn’t respond to a request for comment about the restart.</p><p>The Shanghai restart is a positive even if the persistent Covid issues in China remain a negative. Another negative that may be weighing on shares is a price-target cut on Tesla shares at Daiwa. Analyst Jairam Nathan lowered his price target to $800 from $1,150 but kept his Buy rating. The revision was driven by lower deliveries in 2022 and 2023, partly because of the Shanghai lockdowns.</p><p>Nathan now sees Tesla delivering 1.2 million vehicles in 2022 and 1.8 million in 2023. The Wall Street consensus calls for 1.4 million and 2.1 million units in 2022 and 2023, respectively.</p><p>It’s been a difficult run for Tesla stock lately. Coming into Tuesday trading, it was down about 36% this year, worse than the 16% and 26% respective drops of the S&amp;P 500 and Nasdaq. Tesla shares have moved more than 1%, up or down, eight of the past 10 trading days. Shares have fallen six times and are down about 15% over that span.</p></body></html>","source":"lsy1652258341127","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Stock Falls to an 11-Month Low, Why a Second-Tier Social Media Company Is to Blame</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Stock Falls to an 11-Month Low, Why a Second-Tier Social Media Company Is to Blame\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-25 10:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/tesla-stock-price-snap-wall-street-shanghai-51653391345?mod=search_headline><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla stock tumbles 6.93% on Tuesday. The likeliest reason isn’t related to price-target actions at a broker. However, the drop is probably because of the social-media platform Snap.Snap warned ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/tesla-stock-price-snap-wall-street-shanghai-51653391345?mod=search_headline\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/articles/tesla-stock-price-snap-wall-street-shanghai-51653391345?mod=search_headline","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129162543","content_text":"Tesla stock tumbles 6.93% on Tuesday. The likeliest reason isn’t related to price-target actions at a broker. However, the drop is probably because of the social-media platform Snap.Snap warned investors revenue would be weaker than expected Monday evening at the J.P. Morgan Technology, Media and Telecom conference.“Well, the macroeconomic environment has definitely deteriorated further and faster than we expected when we issued our guidance for the second quarter,” said Snap CEO Evan Spiegel. “So even though our revenue continues to grow year-over-year in the second quarter, it’s likely that revenue and Ebitda will come in below the low end of our guidance range.” (Ebitda is short for earnings before interest, taxes, depreciation, and amortization.)Snap expects second-quarter sales to come in between $1.179 billion and $1.228 billion. Wall Street was modeling $1.184 billion.Snap stock is down 43%, at $12.79 on Tuesday, helping to drive the Nasdaq Composite down 2.35%. Tesla stock (TSLA) is off 6.94%, at $628.16. It would the lowest level since June 2021 if it were to close there.Tesla is falling despite having made some progress on restoring its Shanghai plant to full production. Tesla is quarantining workers in preparation for a second shift at the Shanghai plant, Bloomberg reported Tuesday. Workers have to be Covid-19-free and isolated for the plant to operate in a “closed loop” setting—essentially having virus-free workers who have no contact with the outside world.Tesla’s Shanghai plant was shut completely for weeks in early April. The plant has been operating at reduced capacity since late that month. Many workers are living at the plant, largely because it’s an opportunity to get paid after weeks of isolating at home. Tesla didn’t respond to a request for comment about the restart.The Shanghai restart is a positive even if the persistent Covid issues in China remain a negative. Another negative that may be weighing on shares is a price-target cut on Tesla shares at Daiwa. Analyst Jairam Nathan lowered his price target to $800 from $1,150 but kept his Buy rating. The revision was driven by lower deliveries in 2022 and 2023, partly because of the Shanghai lockdowns.Nathan now sees Tesla delivering 1.2 million vehicles in 2022 and 1.8 million in 2023. The Wall Street consensus calls for 1.4 million and 2.1 million units in 2022 and 2023, respectively.It’s been a difficult run for Tesla stock lately. Coming into Tuesday trading, it was down about 36% this year, worse than the 16% and 26% respective drops of the S&P 500 and Nasdaq. Tesla shares have moved more than 1%, up or down, eight of the past 10 trading days. Shares have fallen six times and are down about 15% over that span.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022982212,"gmtCreate":1653455964036,"gmtModify":1676535286078,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982212","repostId":"2238308566","repostType":4,"repost":{"id":"2238308566","pubTimestamp":1653444032,"share":"https://ttm.financial/m/news/2238308566?lang=&edition=fundamental","pubTime":"2022-05-25 10:00","market":"us","language":"en","title":"Snap Stock Crash: \"Highly Unlikely That the Weakness Is Isolated,\" Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2238308566","media":"Yahoo Finance","summary":"Following a grim profit warning Monday from Snap Inc., investors have another excuse to shed tech sh","content":"<html><head></head><body><p>Following a grim profit warning Monday from <a href=\"https://laohu8.com/S/SNAP\">Snap Inc.</a>, investors have another excuse to shed tech shares.</p><p>Snap stock plunged more than 40% on Tuesday — falling below the platform&#39;s initial public offering (IPO) price of $17 — after Snap Inc. CEO Evan Spiegel warned employees that the company will miss its targets for revenue and adjusted earnings in the current quarter.</p><p><img src=\"https://static.tigerbbs.com/51c4d89ce5201ac7b6198f1480e39e4a\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"/></p><p>The collapse in Snap shares has signaled to some analysts on Wall Street that softness could be expected from other digital advertising companies.</p><p>&#34;It is highly unlikely that the weakness is isolated to SNAP, as we expect macro conditions to impact all digital ad names, including FB, GOOG, TWTR, PubMatic, The Trade Desk, and Integral Ad Science Holding Corp,&#34; Brent Thill, an equity analyst at Jefferies, wrote in a note to clients.</p><p>When reporting first-quarter earnings last month, Snap expected revenue growth to be between 20% and 25% and adjusted EBITDA to be between breakeven and $50 million.</p><p>But the company walked back that guidance in an SEC filing on Monday: &#34;Since we issued guidance on April 21, 2022, the macroeconomic environment has deteriorated further and faster than anticipated,&#34; the filing stated. &#34;As a result, we believe it is likely that we will report revenue and adjusted EBITDA below the low end of our Q2 2022 guidance range.&#34;</p><p>The news hit social media stocks hard, sending Snap&#39;s peers tumbling during intraday trading on Tuesday. Shares of Facebook parent <a href=\"https://laohu8.com/S/FB\">Meta </a>, Google parent <a href=\"https://laohu8.com/S/GOOGL\">Alphabet </a>, <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>, and <a href=\"https://laohu8.com/S/PINS\">Pinterest</a> experienced a collective $160 billion wipeout, Bloomberg reported.</p><h2>&#34;The key question&#34; for Snap</h2><p>The market downturn for tech stocks has brought up two key debates, according to an analyst at MKM Partners.</p><p>The first is whether Snap is facing greater macro headwinds than its peers.</p><p>&#34;We listened to a couple of other Internet companies at an investor event, Fiverr (FVRR, Neutral, $34FV) and Bumble (BMBL, Not Rated), and neither seemed to flag incremental macro headwinds since their 1Q earnings reports,&#34; MKM Managing Partner Rohit Kulkarni wrote.</p><p>Second is whether Snap is &#34;facing incremental TikTok and/or Apple ATT app tracking transparency pressures?&#34; he added. &#34;This remains TBD in our opinion, and we hope to learn more over the next few weeks.&#34;</p><p>UBS analyst Lloyd Walmsley echoed these sentiments in a note: &#34;The key question, in our minds, is to understand how much of this is merely macro weakness (which the company can ultimately bounce back from) versus the competitive impact from TikTok (further risk to multiple).&#34;</p><p>Ultimately, however, Walmsley downplayed the risks for Snap earnings.</p><p>&#34;The company emphasized it &#39;likely&#39; would miss the low end but it doesn&#39;t sound like it would miss by a wide margin,&#34; he wrote. &#34;Simple math suggests that growth could exit the quarter below 10% [year-over-year] to get to below the low end of previous guidance, given a +30% start to the quarter.&#34;</p><p>Walmsley added that UBS still sees &#34;an attractive risk/reward skew in SNAP shares from here, though we acknowledge it may be some time before the bull case plays out.&#34;</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snap Stock Crash: \"Highly Unlikely That the Weakness Is Isolated,\" Jefferies Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnap Stock Crash: \"Highly Unlikely That the Weakness Is Isolated,\" Jefferies Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-25 10:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/snap-warning-weakness-jefferies-190259682.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Following a grim profit warning Monday from Snap Inc., investors have another excuse to shed tech shares.Snap stock plunged more than 40% on Tuesday — falling below the platform's initial public ...</p>\n\n<a href=\"https://finance.yahoo.com/news/snap-warning-weakness-jefferies-190259682.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4581":"高盛持仓","BK4561":"索罗斯持仓","TWTR":"Twitter","GOOGL":"谷歌A","BK4514":"搜索引擎","BK4548":"巴美列捷福持仓","BK4516":"特朗普概念","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4553":"喜马拉雅资本持仓","SNAP":"Snap Inc","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","PINS":"Pinterest, Inc.","BK4576":"AR","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4525":"远程办公概念","QNETCN":"纳斯达克中美互联网老虎指数","BK4524":"宅经济概念","BK4508":"社交媒体","BK4077":"互动媒体与服务","BK4527":"明星科技股","BK4538":"云计算","BK4579":"人工智能","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4574":"无人驾驶","GOOG":"谷歌","BK4551":"寇图资本持仓","BK4573":"虚拟现实"},"source_url":"https://finance.yahoo.com/news/snap-warning-weakness-jefferies-190259682.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2238308566","content_text":"Following a grim profit warning Monday from Snap Inc., investors have another excuse to shed tech shares.Snap stock plunged more than 40% on Tuesday — falling below the platform's initial public offering (IPO) price of $17 — after Snap Inc. CEO Evan Spiegel warned employees that the company will miss its targets for revenue and adjusted earnings in the current quarter.The collapse in Snap shares has signaled to some analysts on Wall Street that softness could be expected from other digital advertising companies.\"It is highly unlikely that the weakness is isolated to SNAP, as we expect macro conditions to impact all digital ad names, including FB, GOOG, TWTR, PubMatic, The Trade Desk, and Integral Ad Science Holding Corp,\" Brent Thill, an equity analyst at Jefferies, wrote in a note to clients.When reporting first-quarter earnings last month, Snap expected revenue growth to be between 20% and 25% and adjusted EBITDA to be between breakeven and $50 million.But the company walked back that guidance in an SEC filing on Monday: \"Since we issued guidance on April 21, 2022, the macroeconomic environment has deteriorated further and faster than anticipated,\" the filing stated. \"As a result, we believe it is likely that we will report revenue and adjusted EBITDA below the low end of our Q2 2022 guidance range.\"The news hit social media stocks hard, sending Snap's peers tumbling during intraday trading on Tuesday. Shares of Facebook parent Meta , Google parent Alphabet , Twitter, and Pinterest experienced a collective $160 billion wipeout, Bloomberg reported.\"The key question\" for SnapThe market downturn for tech stocks has brought up two key debates, according to an analyst at MKM Partners.The first is whether Snap is facing greater macro headwinds than its peers.\"We listened to a couple of other Internet companies at an investor event, Fiverr (FVRR, Neutral, $34FV) and Bumble (BMBL, Not Rated), and neither seemed to flag incremental macro headwinds since their 1Q earnings reports,\" MKM Managing Partner Rohit Kulkarni wrote.Second is whether Snap is \"facing incremental TikTok and/or Apple ATT app tracking transparency pressures?\" he added. \"This remains TBD in our opinion, and we hope to learn more over the next few weeks.\"UBS analyst Lloyd Walmsley echoed these sentiments in a note: \"The key question, in our minds, is to understand how much of this is merely macro weakness (which the company can ultimately bounce back from) versus the competitive impact from TikTok (further risk to multiple).\"Ultimately, however, Walmsley downplayed the risks for Snap earnings.\"The company emphasized it 'likely' would miss the low end but it doesn't sound like it would miss by a wide margin,\" he wrote. \"Simple math suggests that growth could exit the quarter below 10% [year-over-year] to get to below the low end of previous guidance, given a +30% start to the quarter.\"Walmsley added that UBS still sees \"an attractive risk/reward skew in SNAP shares from here, though we acknowledge it may be some time before the bull case plays out.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022982370,"gmtCreate":1653455934290,"gmtModify":1676535286055,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>goo","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>goo","text":"$ConocoPhillips(COP)$goo","images":[{"img":"https://community-static.tradeup.com/news/0b558029f15f9c2a1d1fdae5d7657c43","width":"1080","height":"2087"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982370","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026646536,"gmtCreate":1653372440825,"gmtModify":1676535270229,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>hmm","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>hmm","text":"$Apple(AAPL)$hmm","images":[{"img":"https://community-static.tradeup.com/news/d5cb9fa11ff224180a0fd3bb36c390be","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026646536","isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026648741,"gmtCreate":1653372340383,"gmtModify":1676535270213,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>go","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>go","text":"$ConocoPhillips(COP)$go","images":[{"img":"https://community-static.tradeup.com/news/ab78ba759e3eec3e9f0723f1a3c96718","width":"1080","height":"2087"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026648741","isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026917002,"gmtCreate":1653312840606,"gmtModify":1676535258294,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>up","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>up","text":"$ConocoPhillips(COP)$up","images":[{"img":"https://community-static.tradeup.com/news/aa7091d0451c82bb7f51d38cb917cb71","width":"1080","height":"1994"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026917002","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026914943,"gmtCreate":1653312787883,"gmtModify":1676535258269,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>:(","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>:(","text":"$Apple(AAPL)$:(","images":[{"img":"https://community-static.tradeup.com/news/1c9ebf7426914be4aa3c9a2f715c4f84","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026914943","isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9064714845,"gmtCreate":1652369139887,"gmtModify":1676535087102,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714845","repostId":"1163463240","repostType":4,"repost":{"id":"1163463240","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1652362800,"share":"https://ttm.financial/m/news/1163463240?lang=&edition=fundamental","pubTime":"2022-05-12 21:40","market":"us","language":"en","title":"Rivian Shares Surged 10% in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163463240","media":"Tiger Newspress","summary":"The electric-vehicle maker kept its 2022 production outlook intact","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive Inc.</a> stock rose more than 10% in morning trading after the electric-vehicle maker kept its 2022 production outlook intact and tried to assure investors about it was on the right track amid a recent selloff of its shares.</p><p><img src=\"https://static.tigerbbs.com/6d961f504f352bfd3b7af700ea667e6b\" tg-width=\"833\" tg-height=\"676\" referrerpolicy=\"no-referrer\"/></p><p>&#34;We couldn&#39;t be more confident in the path that lies head,&#34; Chief Executive RJ Scaringe told investors on a call after the first-quarter results.</p><p>Rivian has $17 billion in cash, the capacity to build 150,000 vehicle units, and sees &#34;incredible demand&#34; for its EVs, including a cheaper vehicle in the future, &#34;ensuring we are positioning ourselves for significant growth in the coming years,&#34; Scaringe said.</p><p>Rivian made 2,553 vehicles in the quarter and delivered 1,227, generating $95 million in revenue, the company said.</p><p>Analysts polled by FactSet expected the EV maker to report an adjusted loss of $1.49 a share on sales of $133 million.</p><p>The gap between produced and delivered vehicles in the quarter was strictly on timing, not quality issues, Scaringe said.</p><p>Rivian has taken a page from Tesla Inc. and also sells its vehicles directly to consumers, bypassing dealerships.</p><p>The company has worked with suppliers so they can ramp their production and Rivian can meet its demand, Scaringe said. Suppliers have &#34;leaned in,&#34; and that was in part what gave the company the confidence to keep its production goals, the CEO said.</p><p>&#34;We remain focused on ramping production throughout 2022,&#34; the company said in its letter to shareholders.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian Shares Surged 10% in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian Shares Surged 10% in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-12 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/RIVN\">Rivian Automotive Inc.</a> stock rose more than 10% in morning trading after the electric-vehicle maker kept its 2022 production outlook intact and tried to assure investors about it was on the right track amid a recent selloff of its shares.</p><p><img src=\"https://static.tigerbbs.com/6d961f504f352bfd3b7af700ea667e6b\" tg-width=\"833\" tg-height=\"676\" referrerpolicy=\"no-referrer\"/></p><p>&#34;We couldn&#39;t be more confident in the path that lies head,&#34; Chief Executive RJ Scaringe told investors on a call after the first-quarter results.</p><p>Rivian has $17 billion in cash, the capacity to build 150,000 vehicle units, and sees &#34;incredible demand&#34; for its EVs, including a cheaper vehicle in the future, &#34;ensuring we are positioning ourselves for significant growth in the coming years,&#34; Scaringe said.</p><p>Rivian made 2,553 vehicles in the quarter and delivered 1,227, generating $95 million in revenue, the company said.</p><p>Analysts polled by FactSet expected the EV maker to report an adjusted loss of $1.49 a share on sales of $133 million.</p><p>The gap between produced and delivered vehicles in the quarter was strictly on timing, not quality issues, Scaringe said.</p><p>Rivian has taken a page from Tesla Inc. and also sells its vehicles directly to consumers, bypassing dealerships.</p><p>The company has worked with suppliers so they can ramp their production and Rivian can meet its demand, Scaringe said. Suppliers have &#34;leaned in,&#34; and that was in part what gave the company the confidence to keep its production goals, the CEO said.</p><p>&#34;We remain focused on ramping production throughout 2022,&#34; the company said in its letter to shareholders.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163463240","content_text":"Rivian Automotive Inc. stock rose more than 10% in morning trading after the electric-vehicle maker kept its 2022 production outlook intact and tried to assure investors about it was on the right track amid a recent selloff of its shares.\"We couldn't be more confident in the path that lies head,\" Chief Executive RJ Scaringe told investors on a call after the first-quarter results.Rivian has $17 billion in cash, the capacity to build 150,000 vehicle units, and sees \"incredible demand\" for its EVs, including a cheaper vehicle in the future, \"ensuring we are positioning ourselves for significant growth in the coming years,\" Scaringe said.Rivian made 2,553 vehicles in the quarter and delivered 1,227, generating $95 million in revenue, the company said.Analysts polled by FactSet expected the EV maker to report an adjusted loss of $1.49 a share on sales of $133 million.The gap between produced and delivered vehicles in the quarter was strictly on timing, not quality issues, Scaringe said.Rivian has taken a page from Tesla Inc. and also sells its vehicles directly to consumers, bypassing dealerships.The company has worked with suppliers so they can ramp their production and Rivian can meet its demand, Scaringe said. Suppliers have \"leaned in,\" and that was in part what gave the company the confidence to keep its production goals, the CEO said.\"We remain focused on ramping production throughout 2022,\" the company said in its letter to shareholders.","news_type":1},"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064714314,"gmtCreate":1652369106938,"gmtModify":1676535087101,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714314","repostId":"1126701984","repostType":4,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064714920,"gmtCreate":1652369099060,"gmtModify":1676535087094,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714920","repostId":"1126701984","repostType":4,"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064715564,"gmtCreate":1652369055958,"gmtModify":1676535087086,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584622221107394","authorIdStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064715564","repostId":"2234284139","repostType":4,"repost":{"id":"2234284139","pubTimestamp":1652367354,"share":"https://ttm.financial/m/news/2234284139?lang=&edition=fundamental","pubTime":"2022-05-12 22:55","market":"us","language":"en","title":"3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2234284139","media":"Motley Fool","summary":"Analysts think the downturns for these stocks should only be temporary.","content":"<html><head></head><body><p>You might find it hard to be optimistic about the stock market right now. The <b>Nasdaq Composite </b>index is in a bear market. The <b>S&amp;P 500</b> is in a correction. Former high-flying growth stocks are especially getting pummeled.</p><p>However, analysts remain quite optimistic about some stocks. Here are three unstoppable stocks that could soar 58% to 97% over the next 12 months, according to Wall Street.</p><h2>1. <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a></h2><p>The consensus 12-month price target for <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical </a> reflects a 58% premium to the current share price. All the robotic surgical systems maker needs to do to hit that target is to return to where its stock traded in early January.</p><p>Intuitive Surgical has beaten analysts&#39; expectations in both of its quarterly updates so far this year. However, the stock has fallen more than 40% primarily because of worries that growth will slow significantly.</p><p>CEO Gary Guthart acknowledged on Intuitive&#39;s recent first-quarter conference call, &#34;We are challenged by environmental stresses, including regional waves of COVID, staffing pressure at hospitals, component and raw material availability, and logistic delays.&#34; He noted that &#34;it&#39;s difficult to forecast how long these headwinds will persist.&#34;</p><p>But Wall Street analysts know that these challenges will only be temporary ones. The robotic surgical systems market continues to grow. Intuitive Surgical remains the clear leader in that market. It should be only a matter of time before the stock returns to its winning ways.</p><h2>2. <a href=\"https://laohu8.com/S/NVDA\">Nvidia</a></h2><p>There&#39;s a similar story with <a href=\"https://laohu8.com/S/NVDA\">Nvidia </a>. The average analyst price target is 82% higher than the chipmaker&#39;s current share price. Nvidia stock only needs to regain its levels from early December 2021 to nearly reach that target.</p><p>Much of Nvidia&#39;s share decline in recent months has been unrelated to the company&#39;s business performance. Instead, the overall slump for tech stocks has pulled Nvidia down in its wake.</p><p>Nvidia&#39;s revenue continues to increase robustly on nearly every front. The company is best known for its graphics processing units (GPUs) used in gaming apps. However, it probably won&#39;t be long before Nvidia&#39;s biggest revenue source is in the data center market.</p><p>The company also has excellent growth opportunities for its self-driving car technology and its Omniverse metaverse. Even with Nvidia&#39;s shares trading at more than 33 times expected earnings, Wall Street believes that there&#39;s plenty of room for this stock to run.</p><h2>3. <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a></h2><p>It&#39;s probably no coincidence that the stock on this list that has been beaten down the most is also the one that Wall Street is most bullish about. <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> stock has plunged nearly 80% from its peak last summer. And the consensus price target for the stock is close to 97% above its current price.</p><p>Why has 10x Genomics stock fallen so much? The shift away from growth stocks certainly contributed to the decline. 10x also provided disappointing full-year 2022 revenue guidance earlier this year.</p><p>COVID-19 continues to weigh on 10x&#39;s growth. The company delayed the launch of several new products to focus more on developing its new Xenium platform for in situ tissue sequencing. But these aren&#39;t permanent issues for 10x Genomics.</p><p>Importantly, the company still expects to deliver full-year revenue growth in the ballpark of 24%. Over the long term, the demand for 10x Genomics&#39; single-cell genomic sequencing technology should increase significantly. Wall Street seems to recognize that there&#39;s a dynamic of short-term pain but long-term gain with this stock.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-12 22:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You might find it hard to be optimistic about the stock market right now. The Nasdaq Composite index is in a bear market. The S&P 500 is in a correction. Former high-flying growth stocks are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4579":"人工智能","NVDA":"英伟达","BK4543":"AI","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4581":"高盛持仓","BK4504":"桥水持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4529":"IDC概念","ISRG":"直觉外科公司","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","TXG":"10x Genomics, Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2234284139","content_text":"You might find it hard to be optimistic about the stock market right now. The Nasdaq Composite index is in a bear market. The S&P 500 is in a correction. Former high-flying growth stocks are especially getting pummeled.However, analysts remain quite optimistic about some stocks. Here are three unstoppable stocks that could soar 58% to 97% over the next 12 months, according to Wall Street.1. Intuitive SurgicalThe consensus 12-month price target for Intuitive Surgical  reflects a 58% premium to the current share price. All the robotic surgical systems maker needs to do to hit that target is to return to where its stock traded in early January.Intuitive Surgical has beaten analysts' expectations in both of its quarterly updates so far this year. However, the stock has fallen more than 40% primarily because of worries that growth will slow significantly.CEO Gary Guthart acknowledged on Intuitive's recent first-quarter conference call, \"We are challenged by environmental stresses, including regional waves of COVID, staffing pressure at hospitals, component and raw material availability, and logistic delays.\" He noted that \"it's difficult to forecast how long these headwinds will persist.\"But Wall Street analysts know that these challenges will only be temporary ones. The robotic surgical systems market continues to grow. Intuitive Surgical remains the clear leader in that market. It should be only a matter of time before the stock returns to its winning ways.2. NvidiaThere's a similar story with Nvidia . The average analyst price target is 82% higher than the chipmaker's current share price. Nvidia stock only needs to regain its levels from early December 2021 to nearly reach that target.Much of Nvidia's share decline in recent months has been unrelated to the company's business performance. Instead, the overall slump for tech stocks has pulled Nvidia down in its wake.Nvidia's revenue continues to increase robustly on nearly every front. The company is best known for its graphics processing units (GPUs) used in gaming apps. However, it probably won't be long before Nvidia's biggest revenue source is in the data center market.The company also has excellent growth opportunities for its self-driving car technology and its Omniverse metaverse. Even with Nvidia's shares trading at more than 33 times expected earnings, Wall Street believes that there's plenty of room for this stock to run.3. 10x GenomicsIt's probably no coincidence that the stock on this list that has been beaten down the most is also the one that Wall Street is most bullish about. 10x Genomics stock has plunged nearly 80% from its peak last summer. And the consensus price target for the stock is close to 97% above its current price.Why has 10x Genomics stock fallen so much? The shift away from growth stocks certainly contributed to the decline. 10x also provided disappointing full-year 2022 revenue guidance earlier this year.COVID-19 continues to weigh on 10x's growth. The company delayed the launch of several new products to focus more on developing its new Xenium platform for in situ tissue sequencing. But these aren't permanent issues for 10x Genomics.Importantly, the company still expects to deliver full-year revenue growth in the ballpark of 24%. Over the long term, the demand for 10x Genomics' single-cell genomic sequencing technology should increase significantly. Wall Street seems to recognize that there's a dynamic of short-term pain but long-term gain with this stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9022982212,"gmtCreate":1653455964036,"gmtModify":1676535286078,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982212","repostId":"2238308566","repostType":4,"isVote":1,"tweetType":1,"viewCount":393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064714314,"gmtCreate":1652369106938,"gmtModify":1676535087101,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714314","repostId":"1126701984","repostType":4,"isVote":1,"tweetType":1,"viewCount":265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064714920,"gmtCreate":1652369099060,"gmtModify":1676535087094,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714920","repostId":"1126701984","repostType":4,"repost":{"id":"1126701984","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1652363134,"share":"https://ttm.financial/m/news/1126701984?lang=&edition=fundamental","pubTime":"2022-05-12 21:45","market":"us","language":"en","title":"Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming","url":"https://stock-news.laohu8.com/highlight/detail?id=1126701984","media":"Tiger Newspress","summary":"Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming.The Wa","content":"<html><head></head><body><p>Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming.</p><p><img src=\"https://static.tigerbbs.com/51c29fd74b2eed97b6e6478ad16ffeca\" tg-width=\"822\" tg-height=\"679\" width=\"100%\" height=\"auto\"/>The <a href=\"https://laohu8.com/S/DIS\">Walt Disney Co.</a> added more streaming subscribers than expected in the wake of problems at rival Netflix Inc., but warned that it faces weakness in the months to come after the unexpected surge.</p><p>Disney reported the addition of 7.9 million Disney+ subscriptions in its fiscal second quarter for a total of 137.7 million subscribers, and more than 205 million total streaming subscribers to services that also include ESPN+ and Hulu. Those totals were easily higher than analysts expected -- the average forecast called for 135.1 million Disney+ subscribers and 204.4 million total streaming customers, according to FactSet -- and shares initially moved higher in after-hours trading despite an earnings and revenue miss.</p><p>Those gains turned around roughly an hour into the extended session, however, just as Chief Financial Officer Christine McCarthy ticked off increased costs Disney faces and warned that Disney may have hurt its subscriber growth in the second half with its strong performance in the first half of its fiscal year.</p><p>After adjusting for restructuring costs, amortization and other effects, the company reported earnings of $1.08 a share, compared with adjusted earnings of 32 cents a share a year ago. Analysts surveyed by FactSet had expected adjusted earnings of $1.19 a share on revenue of $20.05 billion.</p><p>&#34;Our strong results in the second quarter, including fantastic performance at our domestic parks and continued growth of our streaming services -- with 7.9 million Disney+ subscribers added in the quarter and total subscriptions across all our DTC offerings exceeding 205 million -- once again proved that we are in a league of our own,&#34; Disney Chief Executive Bob Chapek said in a statement announcing the results.</p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDisney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-12 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming.</p><p><img src=\"https://static.tigerbbs.com/51c29fd74b2eed97b6e6478ad16ffeca\" tg-width=\"822\" tg-height=\"679\" width=\"100%\" height=\"auto\"/>The <a href=\"https://laohu8.com/S/DIS\">Walt Disney Co.</a> added more streaming subscribers than expected in the wake of problems at rival Netflix Inc., but warned that it faces weakness in the months to come after the unexpected surge.</p><p>Disney reported the addition of 7.9 million Disney+ subscriptions in its fiscal second quarter for a total of 137.7 million subscribers, and more than 205 million total streaming subscribers to services that also include ESPN+ and Hulu. Those totals were easily higher than analysts expected -- the average forecast called for 135.1 million Disney+ subscribers and 204.4 million total streaming customers, according to FactSet -- and shares initially moved higher in after-hours trading despite an earnings and revenue miss.</p><p>Those gains turned around roughly an hour into the extended session, however, just as Chief Financial Officer Christine McCarthy ticked off increased costs Disney faces and warned that Disney may have hurt its subscriber growth in the second half with its strong performance in the first half of its fiscal year.</p><p>After adjusting for restructuring costs, amortization and other effects, the company reported earnings of $1.08 a share, compared with adjusted earnings of 32 cents a share a year ago. Analysts surveyed by FactSet had expected adjusted earnings of $1.19 a share on revenue of $20.05 billion.</p><p>&#34;Our strong results in the second quarter, including fantastic performance at our domestic parks and continued growth of our streaming services -- with 7.9 million Disney+ subscribers added in the quarter and total subscriptions across all our DTC offerings exceeding 205 million -- once again proved that we are in a league of our own,&#34; Disney Chief Executive Bob Chapek said in a statement announcing the results.</p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126701984","content_text":"Disney Stock Fell 3.75% in Morning Trading after Warning about Rough Road Ahead for Streaming.The Walt Disney Co. added more streaming subscribers than expected in the wake of problems at rival Netflix Inc., but warned that it faces weakness in the months to come after the unexpected surge.Disney reported the addition of 7.9 million Disney+ subscriptions in its fiscal second quarter for a total of 137.7 million subscribers, and more than 205 million total streaming subscribers to services that also include ESPN+ and Hulu. Those totals were easily higher than analysts expected -- the average forecast called for 135.1 million Disney+ subscribers and 204.4 million total streaming customers, according to FactSet -- and shares initially moved higher in after-hours trading despite an earnings and revenue miss.Those gains turned around roughly an hour into the extended session, however, just as Chief Financial Officer Christine McCarthy ticked off increased costs Disney faces and warned that Disney may have hurt its subscriber growth in the second half with its strong performance in the first half of its fiscal year.After adjusting for restructuring costs, amortization and other effects, the company reported earnings of $1.08 a share, compared with adjusted earnings of 32 cents a share a year ago. Analysts surveyed by FactSet had expected adjusted earnings of $1.19 a share on revenue of $20.05 billion.\"Our strong results in the second quarter, including fantastic performance at our domestic parks and continued growth of our streaming services -- with 7.9 million Disney+ subscribers added in the quarter and total subscriptions across all our DTC offerings exceeding 205 million -- once again proved that we are in a league of our own,\" Disney Chief Executive Bob Chapek said in a statement announcing the results.","news_type":1},"isVote":1,"tweetType":1,"viewCount":112,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022982481,"gmtCreate":1653455992143,"gmtModify":1676535286078,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982481","repostId":"1129162543","repostType":4,"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9026914943,"gmtCreate":1653312787883,"gmtModify":1676535258269,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>:(","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>:(","text":"$Apple(AAPL)$:(","images":[{"img":"https://community-static.tradeup.com/news/1c9ebf7426914be4aa3c9a2f715c4f84","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026914943","isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9064714845,"gmtCreate":1652369139887,"gmtModify":1676535087102,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064714845","repostId":"1163463240","repostType":4,"isVote":1,"tweetType":1,"viewCount":392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064715564,"gmtCreate":1652369055958,"gmtModify":1676535087086,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064715564","repostId":"2234284139","repostType":4,"repost":{"id":"2234284139","pubTimestamp":1652367354,"share":"https://ttm.financial/m/news/2234284139?lang=&edition=fundamental","pubTime":"2022-05-12 22:55","market":"us","language":"en","title":"3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2234284139","media":"Motley Fool","summary":"Analysts think the downturns for these stocks should only be temporary.","content":"<html><head></head><body><p>You might find it hard to be optimistic about the stock market right now. The <b>Nasdaq Composite </b>index is in a bear market. The <b>S&amp;P 500</b> is in a correction. Former high-flying growth stocks are especially getting pummeled.</p><p>However, analysts remain quite optimistic about some stocks. Here are three unstoppable stocks that could soar 58% to 97% over the next 12 months, according to Wall Street.</p><h2>1. <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a></h2><p>The consensus 12-month price target for <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical </a> reflects a 58% premium to the current share price. All the robotic surgical systems maker needs to do to hit that target is to return to where its stock traded in early January.</p><p>Intuitive Surgical has beaten analysts&#39; expectations in both of its quarterly updates so far this year. However, the stock has fallen more than 40% primarily because of worries that growth will slow significantly.</p><p>CEO Gary Guthart acknowledged on Intuitive&#39;s recent first-quarter conference call, &#34;We are challenged by environmental stresses, including regional waves of COVID, staffing pressure at hospitals, component and raw material availability, and logistic delays.&#34; He noted that &#34;it&#39;s difficult to forecast how long these headwinds will persist.&#34;</p><p>But Wall Street analysts know that these challenges will only be temporary ones. The robotic surgical systems market continues to grow. Intuitive Surgical remains the clear leader in that market. It should be only a matter of time before the stock returns to its winning ways.</p><h2>2. <a href=\"https://laohu8.com/S/NVDA\">Nvidia</a></h2><p>There&#39;s a similar story with <a href=\"https://laohu8.com/S/NVDA\">Nvidia </a>. The average analyst price target is 82% higher than the chipmaker&#39;s current share price. Nvidia stock only needs to regain its levels from early December 2021 to nearly reach that target.</p><p>Much of Nvidia&#39;s share decline in recent months has been unrelated to the company&#39;s business performance. Instead, the overall slump for tech stocks has pulled Nvidia down in its wake.</p><p>Nvidia&#39;s revenue continues to increase robustly on nearly every front. The company is best known for its graphics processing units (GPUs) used in gaming apps. However, it probably won&#39;t be long before Nvidia&#39;s biggest revenue source is in the data center market.</p><p>The company also has excellent growth opportunities for its self-driving car technology and its Omniverse metaverse. Even with Nvidia&#39;s shares trading at more than 33 times expected earnings, Wall Street believes that there&#39;s plenty of room for this stock to run.</p><h2>3. <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a></h2><p>It&#39;s probably no coincidence that the stock on this list that has been beaten down the most is also the one that Wall Street is most bullish about. <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> stock has plunged nearly 80% from its peak last summer. And the consensus price target for the stock is close to 97% above its current price.</p><p>Why has 10x Genomics stock fallen so much? The shift away from growth stocks certainly contributed to the decline. 10x also provided disappointing full-year 2022 revenue guidance earlier this year.</p><p>COVID-19 continues to weigh on 10x&#39;s growth. The company delayed the launch of several new products to focus more on developing its new Xenium platform for in situ tissue sequencing. But these aren&#39;t permanent issues for 10x Genomics.</p><p>Importantly, the company still expects to deliver full-year revenue growth in the ballpark of 24%. Over the long term, the demand for 10x Genomics&#39; single-cell genomic sequencing technology should increase significantly. Wall Street seems to recognize that there&#39;s a dynamic of short-term pain but long-term gain with this stock.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-12 22:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You might find it hard to be optimistic about the stock market right now. The Nasdaq Composite index is in a bear market. The S&P 500 is in a correction. Former high-flying growth stocks are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4579":"人工智能","NVDA":"英伟达","BK4543":"AI","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4581":"高盛持仓","BK4504":"桥水持仓","BK4549":"软银资本持仓","BK4548":"巴美列捷福持仓","BK4529":"IDC概念","ISRG":"直觉外科公司","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","TXG":"10x Genomics, Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.fool.com/investing/2022/05/12/3-unstoppable-stocks-that-could-soar-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2234284139","content_text":"You might find it hard to be optimistic about the stock market right now. The Nasdaq Composite index is in a bear market. The S&P 500 is in a correction. Former high-flying growth stocks are especially getting pummeled.However, analysts remain quite optimistic about some stocks. Here are three unstoppable stocks that could soar 58% to 97% over the next 12 months, according to Wall Street.1. Intuitive SurgicalThe consensus 12-month price target for Intuitive Surgical  reflects a 58% premium to the current share price. All the robotic surgical systems maker needs to do to hit that target is to return to where its stock traded in early January.Intuitive Surgical has beaten analysts' expectations in both of its quarterly updates so far this year. However, the stock has fallen more than 40% primarily because of worries that growth will slow significantly.CEO Gary Guthart acknowledged on Intuitive's recent first-quarter conference call, \"We are challenged by environmental stresses, including regional waves of COVID, staffing pressure at hospitals, component and raw material availability, and logistic delays.\" He noted that \"it's difficult to forecast how long these headwinds will persist.\"But Wall Street analysts know that these challenges will only be temporary ones. The robotic surgical systems market continues to grow. Intuitive Surgical remains the clear leader in that market. It should be only a matter of time before the stock returns to its winning ways.2. NvidiaThere's a similar story with Nvidia . The average analyst price target is 82% higher than the chipmaker's current share price. Nvidia stock only needs to regain its levels from early December 2021 to nearly reach that target.Much of Nvidia's share decline in recent months has been unrelated to the company's business performance. Instead, the overall slump for tech stocks has pulled Nvidia down in its wake.Nvidia's revenue continues to increase robustly on nearly every front. The company is best known for its graphics processing units (GPUs) used in gaming apps. However, it probably won't be long before Nvidia's biggest revenue source is in the data center market.The company also has excellent growth opportunities for its self-driving car technology and its Omniverse metaverse. Even with Nvidia's shares trading at more than 33 times expected earnings, Wall Street believes that there's plenty of room for this stock to run.3. 10x GenomicsIt's probably no coincidence that the stock on this list that has been beaten down the most is also the one that Wall Street is most bullish about. 10x Genomics stock has plunged nearly 80% from its peak last summer. And the consensus price target for the stock is close to 97% above its current price.Why has 10x Genomics stock fallen so much? The shift away from growth stocks certainly contributed to the decline. 10x also provided disappointing full-year 2022 revenue guidance earlier this year.COVID-19 continues to weigh on 10x's growth. The company delayed the launch of several new products to focus more on developing its new Xenium platform for in situ tissue sequencing. But these aren't permanent issues for 10x Genomics.Importantly, the company still expects to deliver full-year revenue growth in the ballpark of 24%. Over the long term, the demand for 10x Genomics' single-cell genomic sequencing technology should increase significantly. Wall Street seems to recognize that there's a dynamic of short-term pain but long-term gain with this stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022985320,"gmtCreate":1653456036560,"gmtModify":1676535286094,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022985320","repostId":"1135977592","repostType":4,"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9022982370,"gmtCreate":1653455934290,"gmtModify":1676535286055,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>goo","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>goo","text":"$ConocoPhillips(COP)$goo","images":[{"img":"https://community-static.tradeup.com/news/0b558029f15f9c2a1d1fdae5d7657c43","width":"1080","height":"2087"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9022982370","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026646536,"gmtCreate":1653372440825,"gmtModify":1676535270229,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>hmm","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>hmm","text":"$Apple(AAPL)$hmm","images":[{"img":"https://community-static.tradeup.com/news/d5cb9fa11ff224180a0fd3bb36c390be","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026646536","isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026648741,"gmtCreate":1653372340383,"gmtModify":1676535270213,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>go","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>go","text":"$ConocoPhillips(COP)$go","images":[{"img":"https://community-static.tradeup.com/news/ab78ba759e3eec3e9f0723f1a3c96718","width":"1080","height":"2087"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026648741","isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9026917002,"gmtCreate":1653312840606,"gmtModify":1676535258294,"author":{"id":"3584622221107394","authorId":"3584622221107394","name":"reallyyy","avatar":"https://community-static.tradeup.com/news/d744b0b98fe669cfad1581ab709b48bd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3584622221107394","idStr":"3584622221107394"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>up","listText":"<a href=\"https://ttm.financial/S/COP\">$ConocoPhillips(COP)$</a>up","text":"$ConocoPhillips(COP)$up","images":[{"img":"https://community-static.tradeup.com/news/aa7091d0451c82bb7f51d38cb917cb71","width":"1080","height":"1994"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9026917002","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}